✦ LIBER ✦

A novel non nucleoside compound with high in vitro anti-HIV-1 activity. Absolute stereochemistry determination

✍ Scribed by Jesús A. De la Fuente; Juan J. Marugán; Sue S. Cross; Alfonso F. Mateos; Santiago García; Amador Menéndez

Book ID: 103982996
Publisher: Elsevier Science
Year: 1995
Tongue: English
Weight: 197 KB
Volume: 5
Category: Article
ISSN: 0960-894X
DOI: 10.1016/0960-894x(95)00260-z

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

The inhibition of human immunodeficiency

The inhibition of human immunodeficiency virus type 1 in vitro by a non-nucleoside reverse transcriptase inhibitor MKC-442, alone and in combination with other anti-HIV compounds

✍ Tara M. Brennan; Debra L. Taylor; C.Gordon Bridges; James P. Leyda; A.Stanley Ty 📂 Article 📅 1995 🏛 Elsevier Science 🌐 English ⚖ 865 KB

Non-Nucleoside HIV-1 Reverse-Transcripta

Non-Nucleoside HIV-1 Reverse-Transcriptase Inhibitors. Part 10 : Synthesis and Anti-HIV Activity of 5-Alkyl-6-(1-naphthylmethyl)pyrimidin-4(3H)-ones with a Mono- or Disubstituted 2-Amino Function as Novel ‘Dihydro-Alkoxy-Benzyl-Oxopyrimidine’ (DABO) Analogues

✍ Yueping Wang; Fen-Er Chen; Jan Balzarini; Erik De Clercq; Christophe Pannecouque 📂 Article 📅 2008 🏛 John Wiley and Sons 🌐 English ⚖ 227 KB 👁 2 views

Computer-Aided Design, Synthesis, and An

Computer-Aided Design, Synthesis, and Anti-HIV-1 Activity in Vitro of 2-Alkylamino-6-[1-(2,6-difluorophenyl)alkyl]-3,4-dihydro-5-alkylpyrimidin-4(3 H )- ones as Novel Potent Non-Nucleoside Reverse Transcriptase Inhibitors, Also Active Against the Y181C Variant

✍ Ragno, Rino; Mai, Antonello; Sbardella, Gianluca; Artico, Marino; Massa, Silvio; 📂 Article 📅 2004 🏛 American Chemical Society 🌐 English ⚖ 245 KB

180 Mappicine ketone is a novel non-nucl

180 Mappicine ketone is a novel non-nucleoside inhibitor with in vitro antiviral activity against herpesviruses: D. M. Lambert1, S. Barney1, R. Wittrock1, H. S. Allaudeen2, M. Massare1, W. Kingsbury1, D. Berges1, G. Gallagher1, J. Taggart1, G. Hofmann1, M. Mattern1, R. Hertzberg1, R. Johnson1 and S. R. Petteway, Jr.1, 1SmithKline Beecham Pharmaceuticals, King of Prussia, PA USA and 2Cytrx Corporation, Norcross, GA USA (current address)

📂 Article 📅 1993 🏛 Elsevier Science 🌐 English ⚖ 73 KB